Dissemin is shutting down on January 1st, 2025
Dissemin
Language
العربيّة
Deutsch
English
Español
Suomi
Français
한국어
Македонски
Português
Português Brasileiro
Русский
Svenska
Türkçe
简体中文
繁體中文
Login
Dissemin
Daniel Deangelo
Kantarjian et al., 2023
Links
ORCID
Tools
Export citation
×
Format
BibTeX
@misc{Kantarjian2023, author = {Kantarjian, Hagop M. and Stock, Wendy and Cassaday, Ryan D. and DeAngelo, Daniel J. and Jabbour, Elias and O'Brien, Susan M. and Stelljes, Matthias and Wang, Tao and Luisa Paccagnella, M. and Nguyen, Kevin and Sleight, Barbara and Vandendries, Erik and Neuhof, Alexander and Douglas Laird, A. and Advani, Anjali S.}, month = {mar}, title = {Data from Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22}, year = {2023} }
Export citation
Search in Google Scholar
Data from Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22
Published in 2023 by
Hagop M. Kantarjian
,
Wendy Stock
,
Ryan D. Cassaday
,
Daniel J. DeAngelo
,
Elias Jabbour
,
Susan M. O'Brien
,
Matthias Stelljes
,
Tao Wang
,
M. Luisa Paccagnella
,
Kevin Nguyen
,
Barbara Sleight
,
Erik Vandendries
,
Alexander Neuhof
,
A. Douglas Laird
,
Anjali S. Advani
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text:
Unavailable
Preprint
: policy unknown
Upload
Postprint
: policy unknown
Upload
Published version
: policy unknown
Upload